Trump Administration Secures Major Drug Price Cuts for Popular Weight-Loss Treatments
Nov 6, 2025
President Donald Trump announced major deals with drugmakers Eli Lilly and Novo Nordisk to cut prices for widely-used weight-loss medications. The agreement aims to make these drugs, which include GLP-1-based obesity treatments, significantly more affordable for Americans.
As part of the deal, prices for these weight-loss medications will be lowered by up to 74%. Some patients currently pay over $1,300 per month; with the new agreement, prices may drop to as low as $149 per month for some users.
The lower prices will be available to certain Medicare and Medicaid patients, and consumers who buy through a new government website, TrumpRx.gov, launching in January 2026.
The deal also starts a pilot program for Medicare Part D (the prescription drug benefit for seniors) to cover these obesity drugs, including Eli Lilly’s Zepbound and orforglipron (if approved), which will be offered at $50 per month for eligible beneficiaries.
Novo Nordisk stated that these changes are expected to lower its global sales slightly in 2026, as the company adjusts to the new pricing model in the U.S.
What drugs are included in this price cut?
The agreement covers popular GLP-1-based weight-loss drugs from Eli Lilly and Novo Nordisk, including medications like Zepbound and upcoming oral pills.
Who will benefit from the lower prices?
Lower prices will be available to U.S. Medicare and Medicaid patients, and to anyone who uses the TrumpRx.gov website once it launches.
When do these changes take effect?
The new prices and expanded access are set to begin in January 2026 with the launch of TrumpRx.gov and the Medicare Part D pilot program.
Why are the companies lowering their prices?
The companies made the agreement with the U.S. government to make these important medications more affordable and accessible to more Americans.
Sources
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug pri...
CNBC
CNBC
President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly blockbuster treatments. The agreements will lower prices of GLP-1 drugs on Medicare and Medicaid a...
Trump White House confirms pricing deal with weight-loss-drug giants Eli Lilly,...
Market Watch
Market Watch
President Donald Trump's administration confirmed Thursday that it has reached a deal with Eli Lilly and Novo Nordisk that aims to deliver lower prices for their popular GLP-1 drugs to certain Medicare and Medicaid beneficiaries and to users of TrumpRx.gov, the administration's new direct-to-consume...
Novo Nordisk announces agreement with the U.S. Administration to bring GLP-1s to...
GlobeNewsWire
GlobeNewsWire
Obesity medicines coverage in U.S. Medicare Part D via a pilot programme, starting during 2026. Introduction of lower prices for Novo Nordisk's semaglutide medicines in U.S. Medicare Part D and Medicaid and in direct-to-patients cash channel.
President Trump announces deals with Eli Lilly, Novo Nordisk to slash weight los...
CNBC Television
CNBC Television
President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, including upcoming pills, in a landmark effort to expand access to the costly blockbuster treatments.
Novo Nordisk expects global sales to decline by low single digits in 2026
Reuters
Reuters
Novo Nordisk expects global sales to decline by low-single-digit percentage in 2026 after the drugmaker unveiled a deal on Thursday to slash prices of popular GLP-1 weight‑loss drugs for U.S. government-backed insurance programs and cash payers.
Lilly, Novo Will Lower Obesity Drug Prices in Trump Deal
Bloomberg Markets and Finance
Bloomberg Markets and Finance
Eli Lilly & Co. and Novo Nordisk A/S cut a deal with the Trump administration to lower prices on their blockbuster weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. President Donald Trump spoke about it in the Oval Office.
Eli Lilly, Novo Nordisk Make Weight-Loss Drugs More Affordable Via Medicare, Med...
Benzinga
Benzinga
President Donald Trump on Thursday announced agreements with Eli Lilly and Co. (NYSE:LLY) and Novo Nordisk A/S (NYSE:NVO) to significantly reduce prices for their GLP-1-based obesity and diabetes drugs.
Lilly and U.S. government agree to expand access to obesity medicines to million...
Medicare beneficiaries with obesity or overweight will have access to Zepbound and orforglipron, if approved, at $50 a month INDIANAPOLIS , Nov. 6, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced an agreement with the U.S. government to expand access to its obesity medicines...
Trump Slashes Weight-Loss Drug Prices By Up To 74% In Deal With Lilly, Novo
Investors Business Daily
Investors Business Daily
The Trump administration announced deals Thursday with Eli Lilly and Novo Nordisk to slash the prices of their weight-loss drugs.
Trump strikes deal with Eli Lilly, Novo Nordisk to cut GLP-1 weight-loss drug pr...
Invezz
Invezz
President Donald Trump announced a landmark agreement Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to dramatically slash prices for their blockbuster weight-loss drugs, potentially cutting monthly costs from over $1,300 to as low as $149.
Here's how much weight loss drugs could cost you under Trump's deals with Eli Li...
CNBC
CNBC
President Donald Trump struck landmark deals with Eli Lilly and Novo Nordisk to slash the prices of their blockbuster weight loss drugs. Under the agreements, the monthly out-of-pocket cost of popular injections and upcoming pills could range from $50 to $350, depending on the dosage and insurance...
Trump administration reaches deal to lower prices of obesity and diabetes drugs
Proactive Investors
Proactive Investors
The Trump administration has announced agreements with pharmaceutical companies Novo Nordisk (NYSE:NVO) and Eli Lilly and Co (NYSE:LLY) to reduce the cost of GLP-1 medications used to treat obesity, diabetes, and related conditions. The initiative seeks to expand access and affordability for million...
Eli Lilly and Novo Nordisk lower GLP-1 drug costs in new deal with Trump.
Yahoo Finance
Yahoo Finance
Eli Lilly and Novo Nordisk lower GLP-1 drug costs in new deal with Trump.
Eli Lilly expects US FDA approval for oral obesity drug in March 2026
Reuters
Reuters
Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March 2026, its chief executive said on Thursday.
Lily, Novo cut prices on Wegovy and Zepbound in exchange for deal on tariffs
Bloomberg Markets and Finance
Bloomberg Markets and Finance
Eli Lilly & Co. and Novo Nordisk A/S secured deals with the Trump administration to slash prices for their weight-loss drugs in exchange for tariff relief and wider access for Medicare patients. President Trump spoke about the deal earlier today from the Oval Office.
Novo Nordisk shares fall after deal with Trump to slash obesity drug prices
Reuters
Reuters
Shares in Novo Nordisk fell at opening on Friday, after the Wegovy-maker and rival Eli Lilly struck a deal late on Thursday with U.S. President Donald Trump to slash prices of their GLP-1 weight-loss drugs.
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A F...
Investors Business Daily
Investors Business Daily
Makers of weight-loss drugs saw their stocks surge in 2024, but no more. Now Trump's price deal adds new questions.
Eli Lilly, Novo Nordisk's Historic GLP-1 Pricing Deals - What Investors Need To...
Seeking Alpha
Seeking Alpha
Novo Nordisk A/S and Eli Lilly and Company have agreed to slash US prices for Ozempic, Wegovy, Mounjaro, and Zepbound, expanding Medicare/Medicaid access. NVO's stock has dropped sharply in 2025, but the new deal could boost long-term revenue by increasing drug accessibility and wiping out compounde...
Zepbound Maker Eli Lilly Stock Weighs In On Trump Weight-Loss Drug Deal
Investors Business Daily
Investors Business Daily
Eli Lilly stock is nearing a buy point and a high. The White House signed a historic deal to slash obesity drug prices.
Why Omada Health is finally prescribing Ozempic as TrumpRx slashes GLP-1 weight-...
Business Insider
Business Insider
Trump said Thursday that TrumpRx would offer discounts on GLP-1 drugs for weight loss. A few hours later, Omada Health said it will prescribe the drugs starting in 2026.
Related Posts
Other News
Corporate Moves
View All
Amazon May End US Postal Service Partnership to Expand Own Delivery Network
18 hours ago
AMZN
-1.41%
Amazon is reportedly considering ending its long-running contract with the United States Postal Service (USPS). This change would allow Amazon to rely more on its own growing nationwide delivery netwo...
Meta to Make Deep Cuts to Metaverse Budget as AI Becomes Priority
20 hours ago
META
+3.43%
Meta Platforms CEO Mark Zuckerberg plans to significantly cut spending on the company's metaverse efforts, according to reports from Bloomberg News. The expected budget cuts could be as much as 30% fo...
Meta Hires Apple Design Executive Alan Dye to Lead New Creative Studio
Dec 4, 2025
AAPL
-1.21%
META
+3.43%
Meta Platforms has hired Alan Dye, who was Apple's head of user interface design for the past decade. Dye is leaving Apple to lead a new creative studio within Meta's Reality Labs division.
The new s...
Product Launches
View All
Amazon Unveils New AI Chips and Tools to Boost Cloud Capabilities
Dec 2, 2025
AMZN
-1.41%
Amazon Web Services (AWS) has introduced new artificial intelligence (AI) chips and software tools aimed at improving the performance and reliability of its cloud computing services.
A key highlight...
Samsung Launches World’s First Triple-Folding Smartphone, the Galaxy Z TriFold
Dec 2, 2025
005930
+3.14%
Samsung Electronics has unveiled its first multi-folding smartphone, the Galaxy Z TriFold. This new device folds inward twice, creating a three-panel design with a large 10-inch inner display.
The la...
Amazon and Google Launch Joint Multicloud Networking Service
Dec 1, 2025
GOOGL
-0.63%
AMZN
-1.41%
Amazon and Google have announced a new multicloud networking service to improve connectivity between their cloud platforms. This jointly developed solution is designed to provide businesses with a fas...
Regulatory Actions
View All
New York Times Sues Pentagon Over Restrictive Press Rules
16 hours ago
NYT
-0.25%
The New York Times has filed a lawsuit against the U.S. Department of Defense and Defense Secretary Pete Hegseth over new press rules at the Pentagon. The newspaper claims that the new policy restrict...
EU Launches Antitrust Investigation into Meta’s Use of AI in WhatsApp
Dec 4, 2025
META
+3.43%
The European Union has started an antitrust investigation into Meta Platforms, the company that owns WhatsApp, over its use of artificial intelligence (AI) features within the messaging app.
EU regul...
Costco Sues U.S. Government to Recover Tariff Payments Imposed Under Trump Administration
Dec 2, 2025
COST
-2.86%
Costco has filed a lawsuit against the U.S. government, seeking to recover tariffs it paid on imported goods under orders made by former President Donald Trump. The case focuses on tariffs enacted und...
Earnings
View All
Rubrik Shares Surge After Better-Than-Expected Q3 Fiscal 2026 Results
13 hours ago
RBRK
-1.37%
Rubrik, Inc. (NYSE: RBRK) reported its financial results for the third quarter of fiscal year 2026, ending October 31, 2025. The company announced record net new subscription annual recurring revenue...
Samsara Reports Strong Q3 Results with First Profit, Stock Reaction Mixed
13 hours ago
IOT
+4.36%
Samsara Inc. (NYSE: IOT), a company specializing in connected operations platforms, announced strong financial results for the third quarter of fiscal year 2026.
The company reported $416 million in...
HPE Reports Strong Q4 Profits but Sees Lower Revenue Ahead
14 hours ago
HPE
+2.88%
Hewlett Packard Enterprise (HPE) reported its financial results for the fourth quarter of fiscal 2025, ending October 31. The company delivered profitable growth and completed its acquisition of Junip...
Stock Movements
View All
D-Wave Quantum Stock Experiences Volatility Amid Valuation Concerns and Industry Advances
7 hours ago
QBTS
+14.55%
D-Wave Quantum (QBTS) stock has recently faced significant fluctuations. Over the past 21 trading days, the stock declined by about 24.2%, drawing attention to concerns over the company's high valuati...
SoFi Announces $1.5 Billion Public Offering, Stock Falls Over 6%
8 hours ago
SOFI
+1.82%
SoFi Technologies, a financial technology company, has launched a public offering to sell $1.5 billion worth of its common stock. The company priced 54,545,454 shares at $27.50 each. All of the shares...
Nvidia Gains as AI Chip Demand Rises and Export Challenges Ease
22 hours ago
NVDA
+2.11%
Nvidia's stock price rose after reports that the company has won a political battle involving restrictions on AI chip exports. Nvidia has faced uncertainty due to potential limits on selling its advan...
Economy
View All
ADP Report: Private Sector Lost 32,000 Jobs in November, Wages Up 4.4% Over Year
Dec 3, 2025
According to the November ADP National Employment Report, private sector employment in the United States decreased by 32,000 jobs. This data was compiled by ADP Research in collaboration with the Stan...
Nvidia's AI Chip Leadership Spurs Industry Growth and Component Shortages
Dec 2, 2025
NVDA
+2.11%
Nvidia, a leader in artificial intelligence (AI) chips, continues to drive strong growth in the technology sector. The company has seen high demand for its graphics processing units (GPUs), particular...
Cyber Monday Online Sales in US Expected to Reach $14.2 Billion, UK Shoppers Spend $5 Billion Over Black Friday Weekend
Dec 2, 2025
Adobe Analytics forecasts that U.S. shoppers will spend $14.2 billion online during Cyber Monday. This prediction comes as many consumers continue to look for discounts and promotions while managing t...
Analyst Ratings
View All
‘Big Short’ Investor Michael Burry Calls Tesla ‘Ridiculously Overvalued’
Dec 1, 2025
TSLA
+1.74%
Michael Burry, the investor known for predicting the 2008 financial crisis, has criticized Tesla's stock valuation. In a recent blog post, Burry described Elon Musk's electric car company as 'ridiculo...
Carvana Stock Upgraded by Wedbush, Price Target Raised to $400
Nov 24, 2025
CVNA
+0.97%
Carvana, an online used car retailer, saw its stock rise over 7% on Monday after analysts at Wedbush Securities upgraded the stock from 'Neutral' to 'Outperform.'
Wedbush analysts raised their 12-mon...
Dell Stock Falls After Morgan Stanley Downgrade Over Memory Chip Costs
Nov 17, 2025
DELL
+4.01%
Dell Technologies shares dropped by about 7% to $124.44 after Morgan Stanley downgraded the stock from 'overweight' to 'underweight' and lowered its price target to $110. The downgrade reflects concer...
Mergers & Acquisitions
View All
Hims & Hers Expands Into Canada After Acquiring Digital Health Platform Livewell
16 hours ago
HIMS
+7.96%
Hims & Hers Health, a leading US digital health company, has officially expanded its services into Canada. This move follows its recent acquisition of Livewell, a Canadian digital health platform know...
Netflix Leads Bidding War for Warner Bros. Discovery Amid Investor Concerns
22 hours ago
NFLX
-0.71%
WBD
-0.12%
Warner Bros. Discovery, the company behind HBO and CNN, is currently considering offers from multiple companies, including Netflix, Comcast, and Paramount. According to reports, Warner Bros. prefers N...
Marvell Technology to Acquire Celestial AI in Multi-Billion-Dollar Deal
Dec 2, 2025
MRVL
-2%
Marvell Technology has announced it will acquire Celestial AI, a startup specializing in photonic chip technology, in a cash-and-stock deal valued at over $5 billion. This agreement marks a significan...
IPO
View All
Navan Raises $923 Million in IPO Amid US Government Shutdown
Oct 30, 2025
NAVN
-6.92%
Navan, a business travel and expense management company, has completed its initial public offering (IPO) by selling 36,924,406 shares of its Class A common stock at $25 per share. The IPO raised appro...
Beta Technologies Launches IPO, Aiming to Raise Up to $825 Million
Oct 16, 2025
BETA
+1.15%
Beta Technologies, a company that makes electric aircraft, has set the terms for its initial public offering (IPO) in the United States.
The company plans to offer 25 million shares of its Class A co...
Fermi Shares Surge After High-Profile IPO Despite Lack of Revenue
Oct 2, 2025
FRMI
+8.53%
Fermi Inc., a start-up focused on building large data centers for artificial intelligence, saw its stock price soar following its initial public offerings on both the Nasdaq in New York and the London...
